Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

NCT02058589 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

265

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Herpes Zoster vaccine GSK1437173A
DRUG: Placebo

Sponsor

GlaxoSmithKline